Top

Cancer Imaging

Published in:

Open Access 01-12-2024 | Positron Emission Tomography | Research article

Development and validation of a clinic-radiological model to predict tumor spread through air spaces in stage I lung adenocarcinoma

Authors: Zhaisong Gao, Pingping An, Runze Li, Fengyu Wu, Yuhui Sun, Jie Wu, Guangjie Yang, Zhenguang Wang

Published in: Cancer Imaging | Issue 1/2024

Abstract

Objectives

Tumor spread through air spaces (STAS) is associated with poor prognosis and impacts surgical options. We aimed to develop a user-friendly model based on 2-[¹⁸F] FDG PET/CT to predict STAS in stage I lung adenocarcinoma (LAC).

Materials and methods

A total of 466 stage I LAC patients who underwent 2-[¹⁸F] FDG PET/CT examination and resection surgery were retrospectively enrolled. They were split into a training cohort (n = 232, 20.3% STAS-positive), a validation cohort (n = 122, 27.0% STAS-positive), and a test cohort (n = 112, 29.5% STAS-positive) according to chronological order. Some commonly used clinical data, visualized CT features, and SUV_max were analyzed to identify independent predictors of STAS. A prediction model was built using the independent predictors and validated using the three chronologically separated cohorts. Model performance was assessed using ROC curves and calculations of AUC.

Results

The differences in age (P = 0.009), lesion density subtype (P < 0.001), spiculation sign (P < 0.001), bronchus truncation sign (P = 0.001), and SUV_max (P < 0.001) between the positive and negative groups were statistically significant. Age ≥ 56 years [OR(95%CI):3.310(1.150–9.530), P = 0.027], lesion density subtype (P = 0.004) and SUV_max ≥ 2.5 g/ml [OR(95%CI):3.268(1.021–1.356), P = 0.005] were the independent factors predicting STAS. Logistic regression was used to build the A-D-S (Age-Density-SUV_max) prediction model, and the AUCs were 0.808, 0.786 and 0.806 in the training, validation, and test cohorts, respectively.

Conclusions

STAS was more likely to occur in older patients, in solid lesions and higher SUV_max in stage I LAC. The PET/CT-based A-D-S prediction model is easy to use and has a high level of reliability in diagnosing.

Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.CrossRefPubMed

The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511(7511):543–50. https://doi.org/10.1038/nature13385.ADSCrossRefPubMedCentral

Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors. J Thorac Oncol. 2015;10(9):1243–60. https://doi.org/10.1097/JTO.0000000000000630.CrossRefPubMed

Nicholson AG, Tsao MS, Beasley MB, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol. 2022;17(3):362–87. https://doi.org/10.1016/j.jtho.2021.11.003.CrossRefPubMed

Li J, Wang Y, Li J, et al. Meta-analysis of lobectomy and sublobar resection for stage I non-small cell lung Cancer with spread through air spaces. Clin Lung Cancer. 2022;23(3):208–13. https://doi.org/10.1016/j.cllc.2021.10.004.CrossRefPubMed

Toyokawa G, Yamada Y, Tagawa T, et al. Significance of spread through air spaces in resected pathological stage I lung adenocarcinoma. Ann Thorac Surg. 2018;105(6):1655–63. https://doi.org/10.1016/j.athoracsur.2018.01.037.CrossRefPubMed

Aly RG, Rekhtman N, Li X, et al. Spread through air spaces (STAS) is prognostic in atypical carcinoid, large cell neuroendocrine carcinoma, and small cell carcinoma of the lung. J Thorac Oncol. 2019;14(9):1583–93. https://doi.org/10.1016/j.jtho.2019.05.009.CrossRefPubMedPubMedCentral

Chen S, Ye T, Yang S, et al. Prognostic implication of tumor spread through air spaces in patients with pathologic N0 lung adenocarcinoma. Lung Cancer. 2022;164:33–8. https://doi.org/10.1016/j.lungcan.2021.12.013.CrossRefPubMed

Liu Y, Chen D, Qiu X, et al. Relationship between MTA1 and spread through air space and their joint influence on prognosis of patients with stage I-III lung adenocarcinoma. Lung Cancer. 2018;124:211–8. https://doi.org/10.1016/j.lungcan.2018.07.040.CrossRefPubMed

10.

Kadota K, Kushida Y, Kagawa S, et al. Limited resection is associated with a higher risk of Locoregional recurrence than lobectomy in stage I lung adenocarcinoma with tumor spread through air spaces. Am J Surg Pathol. 2019;43(8):1033–41. https://doi.org/10.1097/PAS.0000000000001285.CrossRefPubMed

11.

Kim SK, Kim TJ, Chung MJ, et al. Lung adenocarcinoma: CT features associated with spread through air spaces. Radiology. 2018;289(3):831–40. https://doi.org/10.1148/radiol.2018180431.CrossRefPubMed

12.

Suh JW, Jeong YH, Cho A, et al. Stepwise flowchart for decision making on sublobar resection through the estimation of spread through air space in early stage lung cancer1. Lung Cancer. 2020;142:28–33. https://doi.org/10.1016/j.lungcan.2020.02.001.CrossRefPubMed

13.

Toyokawa G, Yamada Y, Tagawa T, et al. Computed tomography features of resected lung adenocarcinomas with spread through air spaces. J Thorac Cardiovasc Surg. 2018;156(4):1670–1676.e4. https://doi.org/10.1016/j.jtcvs.2018.04.126.CrossRefPubMed

14.

Li C, Jiang C, Gong J, et al. A CT-based logistic regression model to predict spread through air space in lung adenocarcinoma. Quant Imaging Med Surg. 2020;10(10):1984–93. https://doi.org/10.21037/qims-20-724.CrossRefPubMedPubMedCentral

15.

De Margerie-Mellon C, Onken A, Heidinger BH, et al. CT manifestations of tumor spread through airspaces in pulmonary adenocarcinomas presenting as subsolid nodules. J Thorac Imaging. 2018;33(6):402–8. https://doi.org/10.1097/RTI.0000000000000344.CrossRefPubMed

16.

Qi L, Xue K, Cai Y, et al. Predictors of CT morphologic features to identify spread through air spaces preoperatively in small-sized lung adenocarcinoma. Front Oncol. 2021;10:548430. https://doi.org/10.3389/fonc.2020.548430.CrossRefPubMedPubMedCentral

17.

Chang C, Sun X, Zhao W, et al. Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (≤ 3 cm): PET/CT findings and correlations with lymph node metastasis. Radiol Med (Torino). 2020;125(3):257–64. https://doi.org/10.1007/s11547-019-01112-x.ADSCrossRefPubMed

18.

Altorki N, Wang X, Kozono D, et al. Lobar or sublobar resection for peripheral stage IA non–small-cell lung Cancer. N Engl J Med. 2023;388(6):489–98. https://doi.org/10.1056/NEJMoa2212083.CrossRefPubMedPubMedCentral

19.

Altorki NK, Wang X, Wigle D, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med. 2018;6(12):915–24. https://doi.org/10.1016/S2213-2600(18)30411-9.CrossRefPubMedPubMedCentral

20.

Cao C, Chandrakumar D, Gupta S, et al. Could less be more?—a systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patient selection. Lung Cancer. 2015;89(2):121–32. https://doi.org/10.1016/j.lungcan.2015.05.010.CrossRefPubMed

21.

Eguchi T, Kameda K, Lu S, et al. Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched Analysis. J Thorac Oncol. 2019;14(1):87–98. https://doi.org/10.1016/j.jtho.2018.09.005.CrossRefPubMed

22.

Medina MA, Onken AM, de Margerie-Mellon C, et al. Preoperative bronchial cytology for the assessment of tumor spread through air spaces in lung adenocarcinoma resection specimens. Cancer Cytopathol. 2020;128(4):278–86. https://doi.org/10.1002/cncy.22243.CrossRefPubMed

23.

Walts AE, Marchevsky AM. Current evidence does not warrant frozen section evaluation for the presence of tumor spread through alveolar spaces. Arch Pathol Lab Med. 2018;142(1):59–63. https://doi.org/10.5858/arpa.2016-0635-OA.CrossRefPubMed

24.

Zhou F, Villalba JA, Sayo TMS, et al. Assessment of the feasibility of frozen sections for the detection of spread through air spaces (STAS) in pulmonary adenocarcinoma. Mod Pathol. 2022;35(2):210–7. https://doi.org/10.1038/s41379-021-00875-x.CrossRefPubMed

25.

Chae M, Jeon JH, Chung JH, et al. Prognostic significance of tumor spread through air spaces in patients with stage IA part-solid lung adenocarcinoma after sublobar resection. Lung Cancer. 2021;152:21–6. https://doi.org/10.1016/j.lungcan.2020.12.001.CrossRefPubMed

26.

Jiang C, Luo Y, Yuan J, et al. CT-based radiomics and machine learning to predict spread through air space in lung adenocarcinoma. Eur Radiol. 2020;30(7):4050–7. https://doi.org/10.1007/s00330-020-06694-z.CrossRefPubMed

27.

Koezuka S, Mikami T, Tochigi N, et al. Toward improving prognosis prediction in patients undergoing small lung adenocarcinoma resection: radiological and pathological assessment of diversity and intratumor heterogeneity. Lung Cancer. 2019;135:40–6. https://doi.org/10.1016/j.lungcan.2019.06.023.CrossRefPubMed

28.

Kandathil A, Kay FU, Butt YM, et al. Role of FDG PET/CT in the eighth edition of TNM staging of non–small cell lung Cancer. Radiographics. 2018;38(7):2134–49. https://doi.org/10.1148/rg.2018180060.CrossRefPubMed

29.

Liao G, Huang L, Wu S, et al. Preoperative CT-based peritumoral and tumoral radiomic features prediction for tumor spread through air spaces in clinical stage I lung adenocarcinoma. Lung Cancer. 2022;163:87–95. https://doi.org/10.1016/j.lungcan.2021.11.017.CrossRefPubMed

30.

Altman DG, Vergouwe Y, Royston P, et al. Prognosis and prognostic research: validating a prognostic model. BMJ. 2009:338 b605. https://doi.org/10.1136/bmj.b605.

Title: Development and validation of a clinic-radiological model to predict tumor spread through air spaces in stage I lung adenocarcinoma
Authors: Zhaisong Gao
Pingping An
Runze Li
Fengyu Wu
Yuhui Sun
Jie Wu
Guangjie Yang
Zhenguang Wang
Publication date: 01-12-2024
Publisher: BioMed Central
Keyword: Positron Emission Tomography
Published in: Cancer Imaging / Issue 1/2024
Electronic ISSN: 1470-7330
DOI: https://doi.org/10.1186/s40644-024-00668-w

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2024

Amide proton transfer-weighted imaging and stretch-exponential model DWI based 18F-FDG PET/MRI for differentiation of benign and malignant solitary pulmonary lesions

Relationship of FDG PET/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study

Enhancing local recurrence detection in patients with high-grade soft tissue sarcoma: value of short-term Ultrasonography added to post-operative MRI surveillance

Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer

CT radiomics based on different machine learning models for classifying gross tumor volume and normal liver tissue in hepatocellular carcinoma

Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer